Michael Bonner
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Cumberland Pharmaceuticals Inc (CPIX) | Senior Director of Finance and Accounting and Chief Financial Officer Represents the additions for the Named Executive Officers to the non-contributory, non-qualified defined contribution plan that provides for the payment of benefits from the general funds of the Company. Represents premiums paid for by the Company with respect to life insurance for the benefit of the Named Executive Officers. Mr. Hamm was appointed as the Company's chief financial offer May 17, 2021. | $220,000 | $270,815 |
| 2020 | Cumberland Pharmaceuticals Inc (CPIX) | Senior Director of Finance and Accounting and Chief Financial Officer Represents the additions for the Named Executive Officers to the non-contributory, non-qualified defined contribution plan that provides for the payment of benefits from the general funds of the Company. Represents premiums paid for by the Company with respect to life insurance for the benefit of the Named Executive Officers. Mr. Hamm was appointed as the Company's chief financial offer May 17, 2021. | $205,500 | $255,666 |
| 2019 | Cumberland Pharmaceuticals Inc (CPIX) | Senior Director of Finance and Accounting and Chief Financial Officer Represents the additions for the Named Executive Officers to the non-contributory, non-qualified defined contribution plan that provides for the payment of benefits from the general funds of the Company. Represents premiums paid for by the Company with respect to life insurance for the benefit of the Named Executive Officers. Mr. Hamm was appointed as the Company's chief financial offer May 17, 2021. | $197,600 | $273,066 |
| 2018 | Cumberland Pharmaceuticals Inc (CPIX) | Senior Director of Finance and Accounting and Chief Financial Officer Represents the additions for the Named Executive Officers to the non-contributory, non-qualified defined contribution plan that provides for the payment of benefits from the general funds of the Company. Represents premiums paid for by the Company with respect to life insurance for the benefit of the Named Executive Officers. | $190,000 | $242,266 |
| 2017 | Cumberland Pharmaceuticals Inc (CPIX) | Senior Director of Finance and Accounting and Chief Financial Officer The fair value of restricted stock awards granted during March 2019 equaled $5.98, the closing price of our common stock on the grant date. Represents the additions for the Named Executive Officers to the non-contributory, non-qualified defined contribution plan that provides for the payment of benefits from the general funds of the Company. Represents premiums paid for by the Company with respect to life insurance for the benefit of the Named Executive Officers. | $182,100 | $258,741 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.